跳至主要内容
临床试验/JPRN-UMIN000002096
JPRN-UMIN000002096已完成4 期

A Switch Therapy for Community-acquired Pneumonia: A Randomized Controlled Trial - A Switch Therapy for Community-acquired Pneumonia.

agasaki evaluation organization for clinical interventions0 个研究点目标入组 100 人开始时间: 2009年7月1日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients with episodes of aspiration 2) Patients with thoracic cavity drainage due to lung suppuration or empyema 3) Obstructive pneumonia due to airway obstruction 4) Legionella, MRSA, and P. aeruginosa are causative microorganism. 5) Patients who are treated with more than 10 mg of steroid 6) Patients with infections due to causative microorganism which is regarded as being ineffective to garenoxacin 7) Patients with a history of allergy/severe adverse effect to quinolone antibacterial agents or B-lactum antibacterial agents 8) Patients with a history of seizure/epilepsy or patients who are taking antiepilepsy drug 9) Patients with severe hepatic impairment, renal impairment, and cardiac impairment 10) Pregnancy/lactation 11) Patients who are regarded as inadequate subject by physician in charge

研究者

发起方
agasaki evaluation organization for clinical interventions

相似试验